Stability of clonidine hydrochloride in an oral powder form compounded for pediatric patients in Japan

Stability of clonidine hydrochloride in an oral powder form compounded for pediatric patients in Japan

Abstract Background Clonidine hydrochloride is used to treat sedative agent withdrawals, malignant hypertension, and anesthesia complications. Clonidine is also prescribed off-label to pediatric patients at a dose of 1 μg/kg. The commercially available enteral form of clonidine, Catapres® tablets, i...

Full description

Bibliographic Details
Main Authors: Jumpei Saito, Takehisa Hanawa, Takahiro Matsumoto, Nozomi Yoshikawa, Tsutomu Harada, Kana Iwahashi, Hidefumi Nakamura, Akimasa Yamatani
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Compounding
Pediatric patients
Clonidine hydrochloride
Oral powder form
Stability
Online Access:https://doi.org/10.1186/s40780-021-00214-x

Internet

https://doi.org/10.1186/s40780-021-00214-x

Similar Items